Last updated November 5, 2026
In January 2026, the U.S. Centers for Disease Control and Prevention (CDC) and U.S. Department of Health and Human Services (HHS) announced significant changes to the United States’ recommended pediatric immunization schedule without following established procedures or providing a scientific rationale. As of March 2026, all of those recommendations have been put on hold. If you have specific questions about whether vaccine recommendations have changed or confusion about conflicting information, review PHCC’s “Communicating Vaccine Schedule Information In A Changing Environment” messaging and talking points.
What is Hepatitis B (Hep B)?
- Hepatitis B (Hep B) is a viral infection that causes swelling in the liver.
- Some people infected with Hep B experience a short-term illness, also called acute Hep B. Symptoms include fever, fatigue, loss of appetite, nausea, jaundice, and pain in the muscles, joints, and stomach.
- Acute Hep B can lead to chronic Hep B, a long-term illness that can cause liver damage, liver cancer, liver failure, and death. 90% of newborns and babies infected with Hep B will develop chronic Hep B. Chronic Hep B is fully preventable through vaccination, which infants can receive at birth.
Hep B Transmission
- A person with Hep B can pass the infection to another person through blood and other bodily fluids:
- Infants can contract Hep B during birth if the parent giving birth has Hep B.
- A person may contract Hep B if they share razors, toothbrushes, and needles with a person who has Hep B, if they come into contact with the blood of a person who has Hep B, or if they have sex with someone who has Hep B.
Hep B Vaccination
- The Hep B vaccine is available to anyone ages 59 or younger, as well as to people ages 60 and older who are at an increased risk of Hep B exposure and were not vaccinated previously. Most people who receive the Hep B vaccine are immune for life, and most people do not need a booster dose of the Hep B vaccine later in life.
- Since being adopted as a routine vaccine in 1991, the Hep B vaccine has led to a 99% decline in pediatric Hep B. That’s why the American Academy of Pediatrics (AAP) recommends that all infants receive their first dose of the Hep B vaccine at birth, followed by a second dose at one to two months old and a third dose at six to 18 months old.
Hep B Treatment
- If you or your child are experiencing Hep B symptoms, is at high risk for Hep B, or believe you were exposed to Hep B, contact a healthcare professional. They can recommend treatment based on your age, vaccination status, and other factors.
Sources
American Academy of Pediatrics. (n.d.-a). All about the AAP recommended immunization schedule. HealthyChildren.org. https://www.healthychildren.org/English/safety-prevention/immunizations/Pages/Recommended-Immunization-Schedules.aspx
American Academy of Pediatrics. (n.d.-b). Fact checked: Hepatitis B vaccine given to newborns reduces risk of chronic infection [Fact check]. https://www.aap.org/en/news-room/fact-checked/fact-checked-hepatitis-b-vaccine-given-to-newborns-reduces-risk-of-chronic-infection/
Bigham, J. (2023). Understanding the updated hepatitis B vaccination recommendations and guidance. Family Practice Management, 30(5), 9-12. https://www.aafp.org/fpm/2023/0900/hepatitis-b-vaccination-recommendations
World Health Organization. (n.d.). Hepatitis B [Fact sheet]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b






